181 related articles for article (PubMed ID: 20737330)
1. Intravaginal insertion in KwaZulu-Natal: sexual practices and preferences in the context of microbicide gel use.
Gafos M; Mzimela M; Sukazi S; Pool R; Montgomery C; Elford J
Cult Health Sex; 2010 Nov; 12(8):929-42. PubMed ID: 20737330
[TBL] [Abstract][Full Text] [Related]
2. Educating men about vaginal microbicides: considerations from Kenya.
Gitome SW; Kwena ZA; Harper CC; Cohen CR; Bukusi EA
Cult Health Sex; 2020 Jun; 22(6):660-674. PubMed ID: 31241426
[TBL] [Abstract][Full Text] [Related]
3. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.
Vallely A; Fitzgerald L; Fiya V; Aeno H; Kelly A; Sauk J; Kupul M; Neo J; Millan J; Siba P; Kaldor JM
BMC Res Notes; 2012 Nov; 5():613. PubMed ID: 23116431
[TBL] [Abstract][Full Text] [Related]
4. Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, Kenya.
Montandon M; Sahin-Hodoglugil NN; Bukusi E; Agot K; Boland B; Cohen CR
Sex Health; 2008 Dec; 5(4):339-46. PubMed ID: 19061553
[TBL] [Abstract][Full Text] [Related]
5. Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
Miller L; Morar N; Kapiga S; Ramjee G; Hayes R
J Acquir Immune Defic Syndr; 2020 Dec; 85(4):458-465. PubMed ID: 33136745
[TBL] [Abstract][Full Text] [Related]
6. Challenges to microbicide introduction in South Africa.
Orner P; Harries J; Cooper D; Moodley J; Hoffman M; Becker J; McGrory E; Dabash R; Bracken H
Soc Sci Med; 2006 Aug; 63(4):968-78. PubMed ID: 16600447
[TBL] [Abstract][Full Text] [Related]
7. Microbicide preference among young women in California.
Holt BY; Morwitz VG; Ngo L; Harrison PF; Whaley KJ; Pettifor A; Nguyen AH
J Womens Health (Larchmt); 2006 Apr; 15(3):281-94. PubMed ID: 16620187
[TBL] [Abstract][Full Text] [Related]
8. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa.
Hart CW; Joanis C; Hartmann M; Milford C; Smit J; Beksinska M; Rambally-Greener L; Pienaar J; Mabude Z; Butterworth GAM; Sokal D; Jenkins D
Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):390-398. PubMed ID: 31517545
[No Abstract] [Full Text] [Related]
9. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.
Morrow K; Rosen R; Richter L; Emans A; Forbes A; Day J; Morar N; Maslankowski L; Profy AT; Kelly C; Abdool Karim SS; Mayer KH
J Womens Health (Larchmt); 2003 Sep; 12(7):655-66. PubMed ID: 14583106
[TBL] [Abstract][Full Text] [Related]
10. Communication About Microbicide Use Between Couples in KwaZulu-Natal, South Africa.
Gafos M; Pool R; Mzimela MA; Ndlovu HB; McCormack S; Elford J;
AIDS Behav; 2015 May; 19(5):832-46. PubMed ID: 25488170
[TBL] [Abstract][Full Text] [Related]
11. Covert use, vaginal lubrication, and sexual pleasure: a qualitative study of urban U.S. Women in a vaginal microbicide clinical trial.
Hoffman S; Morrow KM; Mantell JE; Rosen RK; Carballo-Diéguez A; Gai F
Arch Sex Behav; 2010 Jun; 39(3):748-60. PubMed ID: 19636696
[TBL] [Abstract][Full Text] [Related]
12. To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa.
Kelly CA; Friedland BA; Morar NS; Katzen LL; Ramjee G; Mokgatle MM; Ahmed K
Cult Health Sex; 2015; 17(8):1004-20. PubMed ID: 25913101
[TBL] [Abstract][Full Text] [Related]
13. "One teabag is better than four": Participants response to the discontinuation of 2% PRO2000/5 microbicide gel in KwaZulu-Natal, South Africa.
Gafos M; Mzimela M; Ndlovu H; Mhlongo N; Hoogland Y; Mutemwa R
PLoS One; 2011 Jan; 6(1):e14577. PubMed ID: 21344002
[TBL] [Abstract][Full Text] [Related]
14. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
[TBL] [Abstract][Full Text] [Related]
15. The implications of post-coital intravaginal cleansing for the introduction of vaginal microbicides in South Africa.
Gafos M; Pool R; Mzimela MA; Ndlovu HB; McCormack S; Elford J;
AIDS Behav; 2014 Feb; 18(2):297-310. PubMed ID: 24337726
[TBL] [Abstract][Full Text] [Related]
16. 'The study has taught me to be supportive of her': empowering women and involving men in microbicide research.
Venables E; Stadler J
Cult Health Sex; 2012; 14(2):181-94. PubMed ID: 22085043
[TBL] [Abstract][Full Text] [Related]
17. Hidden heterogeneity: Uncovering patterns of adherence in microbicide trials for HIV prevention.
Miller L; Prieto Merino D; Baisley K; Hayes R
PLoS One; 2022; 17(5):e0267011. PubMed ID: 35551324
[TBL] [Abstract][Full Text] [Related]
18. Re-framing microbicide acceptability: findings from the MDP301 trial.
Montgomery CM; Gafos M; Lees S; Morar NS; Mweemba O; Ssali A; Stadler J; Pool R;
Cult Health Sex; 2010 Aug; 12(6):649-62. PubMed ID: 20397079
[TBL] [Abstract][Full Text] [Related]
19. Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews.
Turner AN; De Kock AE; Meehan-Ritter A; Blanchard K; Sebola MH; Hoosen AA; Coetzee N; Ellertson C
J Clin Epidemiol; 2009 Jul; 62(7):759-65. PubMed ID: 19013762
[TBL] [Abstract][Full Text] [Related]
20. An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana.
Abdulai MA; Baiden F; Adjei G; Afari-Asiedu S; Adjei K; Tawiah C; Newton S
BMC Womens Health; 2012 Nov; 12():40. PubMed ID: 23114222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
